These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3312703)

  • 1. [New antimicrobial agent series. XIX: Potassium clavulanate/amoxicillin granules].
    Fujii R
    Jpn J Antibiot; 1987 May; 40(5):933-45. PubMed ID: 3312703
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacokinetics, dosage, tolerance, side effects and safety of the preparation Augmentin (a combination of amoxicillin and clavulanic acid)].
    Robinson OP
    Antibiot Khimioter; 1992 Sep; 37(9):20-3. PubMed ID: 1444662
    [No Abstract]   [Full Text] [Related]  

  • 3. Clavulanic acid inhibits beta-lactamases.
    FDA Drug Bull; 1984 Dec; 14(3):25. PubMed ID: 6335441
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro efficacy of augmentin in beta-lactamase producing bacteria.
    Agrawal SK; Goel MM; Misra AB
    Indian J Med Res; 1987 Sep; 86():298-300. PubMed ID: 3501408
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic data in gynecological surgery using preoperative augmentin.
    Von Kobyletzki V
    Chemioterapia; 1987 Jun; 6(2 Suppl):262-4. PubMed ID: 3509406
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Haruta T; Kuroki S; Okura K; Kobayashi Y
    Jpn J Antibiot; 1985 Feb; 38(2):359-72. PubMed ID: 3847523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmaceutical preparation of BRL 25000].
    Jpn J Antibiot; 1985 Feb; 38(2):538-41. PubMed ID: 3847526
    [No Abstract]   [Full Text] [Related]  

  • 8. Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
    Bywater RJ; Palmer GH; Buswell JF; Stanton A
    Vet Rec; 1985 Jan; 116(2):33-6. PubMed ID: 3871985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of culture medium on the comparative in-vitro activity of amoxycillin and amoxycillin/clavulanic acid against Branhamella catarrhalis.
    Soriano F; Jiménez-Arriero M; Fernández-Roblas R
    J Antimicrob Chemother; 1987 Aug; 20(2):285-6. PubMed ID: 3117763
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of amikacin and amoxicillin-clavulanic acid against Mycobacterium tuberculosis.
    Tamás F
    Chest; 1993 Jul; 104(1):328. PubMed ID: 8325113
    [No Abstract]   [Full Text] [Related]  

  • 11. Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio.
    Thomson CJ; Miles RS; Amyes SG
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2591-2. PubMed ID: 8585755
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Nakazawa S; Suzuki H; Chikaoka H; Tazoe K; Nakada Y; Niino K
    Jpn J Antibiot; 1985 Feb; 38(2):296-308. PubMed ID: 3847519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Sato Y; Iwata S; Akita H; Murai T; Ibara M; Oikawa T; Osano M
    Jpn J Antibiot; 1985 Feb; 38(2):327-41. PubMed ID: 3847521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
    Fujimori I
    Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous amoxycillin and potassium clavulanate in seriously ill children.
    Jones AE; Barnes ND; Tasker TC; Horton R
    J Antimicrob Chemother; 1990 Feb; 25(2):269-74. PubMed ID: 2329104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 17. [[New antibiotics series XIII]: BRL 25000 (clavulanic acid/amoxicillin)].
    Mashimo K
    Jpn J Antibiot; 1985 Aug; 38(8):2011-25. PubMed ID: 3908731
    [No Abstract]   [Full Text] [Related]  

  • 18. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man.
    Fraschini F; Scaglione F; Falchi M; Dugnani S; Mezzetti M; Cicchetti F; Alfano G; Pintucci GP
    J Chemother; 1990 Jun; 2(3):171-7. PubMed ID: 2199627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of amoxicillin and clavulanate.
    Reed MD
    Pediatr Infect Dis J; 1996 Oct; 15(10):949-54. PubMed ID: 8895939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.